Open menu

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

Starpharma Reports Positive VivaGel Clinical Study Results

Starpharma Holdings Limited today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel) was safe and well-tolerated in sexually abstinent women when administered vaginally, twice daily for 14 days.

Posted: May 12th, 2008

Read more